Cargando…
Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are of public health concern, because of their ubiquitous and extremely persistent occurrence, and depending on their structure, their bio-accumulative, mobile and toxic properties. Human health effects associated with exposure to PFAS include a...
Autores principales: | Ehrlich, Veronika, Bil, Wieneke, Vandebriel, Rob, Granum, Berit, Luijten, Mirjam, Lindeman, Birgitte, Grandjean, Philippe, Kaiser, Andreas-Marius, Hauzenberger, Ingrid, Hartmann, Christina, Gundacker, Claudia, Uhl, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944481/ https://www.ncbi.nlm.nih.gov/pubmed/36814257 http://dx.doi.org/10.1186/s12940-022-00958-5 |
Ejemplares similares
-
Immunotoxicity of Per- and Polyfluoroalkyl Substances: Insights into Short-Chain PFAS Exposure
por: Woodlief, Tracey, et al.
Publicado: (2021) -
Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring
por: Bil, Wieneke, et al.
Publicado: (2022) -
Comparison of extraction methods for per- and polyfluoroalkyl substances (PFAS) in human serum and placenta samples—insights into extractable organic fluorine (EOF)
por: Kaiser, Andreas-Marius, et al.
Publicado: (2020) -
Correction: Woodlief et al. Immunotoxicity of Per- and Polyfluoroalkyl Substances: Insights into Short-Chain PFAS Exposure. Toxics 2021, 9, 100
por: Woodlief, Tracey, et al.
Publicado: (2023) -
Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
por: Tow, Emily W., et al.
Publicado: (2021)